Publications (25) Rafael Benito Melero González publications

2024

  1. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

    Journal of Clinical Medicine, Vol. 13, Núm. 20

  2. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

  3. Tumor-induced osteomalacia: A systematic literature review

    Bone Reports, Vol. 21

2023

  1. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

    European Congress of Rheumatology (EULAR)

  2. AB0707 PREDICTIVE FACTORS OF RELAPSE IN GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB

    European Congress of Rheumatology (EULAR)

  3. AB1487 EFFECTIVENESS OF RITUXIMAB IN IGG4-RELATED DISEASE. MULTICENTRE STUDY AND LITERATURE REVIEW

    European Congress of Rheumatology (EULAR)

  4. Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis

    European Journal of Internal Medicine

  5. OP0126 LONG-TERM FOLLOW UP OF ABATACEPT IN USUAL INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 172 PATIENTS

    European Congress of Rheumatology (EULAR), Milan, ITALY

  6. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

  7. POS0035 INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT

    European Congress of Rheumatology (EULAR)

  8. POS0864 EFFECTIVENESS OF ANTIFIBROTICS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 50 PATIENTS IN CLINICAL PRACTICE

    European Congress of Rheumatology (EULAR)

2022

  1. Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology

    BMC Health Services Research, Vol. 22, Núm. 1

  2. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review

    Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436

2021

  1. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients

    Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 299-308

  2. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745

  3. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50

  4. Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis

    Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 571-576

  5. Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice

    Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558

2020

  1. Prevalence and Clinical Impact of Systemic Autoimmune Rheumatic Disease in Patients with Silicosis

    Archivos de Bronconeumologia

2019

  1. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139